论文信息 - Outcomes With First-Line PD-1/PD-L1 Inhibitor Monotherapy for Metastatic Renal Cell Carcinoma (mRCC): A Multi-Institutional Cohort - 字舞流文

Outcomes With First-Line PD-1/PD-L1 Inhibitor Monotherapy for Metastatic Renal Cell Carcinoma (mRCC): A Multi-Institutional Cohort

O. Sartor | P. Barata | A. Desai | V. Koshkin | A. Basu | D. Kilari | J. Layton | M. Bilen | H. Emamekhoo | E. Jaeger | W. Hatton | Brian E. Lewis | Patrick Cotogno | Charlotte Manogue | Malcolm Light